文献速递妇科

子宫托治疗盆腔器官脱垂的作用:系统综述与Meta分析

Role of Pessaries in the Treatment of Pelvic Organ Prolapse: A Systematic Review and Meta-analysis.
PubMed 文献 · Obstet Gynecol · 2022-09-07

该系统综述与Meta分析检索PubMed、EMBASE和CINAHL(2020年3月16日),纳入8项研究共627例患者,评估子宫托治疗盆腔器官脱垂(POP)后标准化问卷评分的变化。结果显示PFDI-20平均变化-46.1(95%CI -65.4至-26.8)、PFIQ-7平均变化-36.0(95%CI -46.0至-26.0)、POPIQ-7平均变化-16.3(95%CI -26.8至-5.7),均提示生活质量改善,作者认为子宫托是POP的有效治疗选择。

要点

  • 子宫托治疗后PFDI-20评分平均改善-46.1(95%CI -65.4至-26.8)。
  • PFIQ-7评分平均改善-36.0(95%CI -46.0至-26.0),POPIQ-7平均改善-16.3(95%CI -26.8至-5.7)。
  • 基于标准化问卷评分的改善,子宫托是POP的有效治疗选择。

核心结论

  • 基于标准化问卷评分的改善,子宫托是盆腔器官脱垂的有效治疗选择。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE和CINAHL(2020年3月16日)及ClinicalTrials.gov(无符合严格纳入排除标准的研究)。
  • 纳入8项报告子宫托治疗前后标准化问卷平均评分及标准差的研究,共627例患者。
  • 由3名评审员独立筛选研究,数据提取按PRISMA指南进行,至少3项研究报告时合并数据行Meta分析。
  • 采用随机效应模型合并估计值,用I²统计量评估研究间异质性。

主要发现

  • 纳入患者平均(标准差)年龄63.0±12.2岁;报告的分期中III期脱垂占48.1%,II期占43.2%。
  • 多数研究随访3个月(各研究不一)。
  • 子宫托使用后问卷评分出现负向变化,提示改善:PFDI-20平均变化-46.1(95%CI -65.4至-26.8)。
  • PFIQ-7平均变化-36.0(95%CI -46.0至-26.0);POPIQ-7平均变化-16.3(95%CI -26.8至-5.7)。
  • 未发现显著异质性。

关键数值与推荐

  • 主要结局为子宫托治疗前后标准化问卷平均评分的变化,包括PFDI-20、PFIQ-7及POPIQ子量表。
  • 纳入标准为报告子宫托治疗前后标准化问卷平均评分及标准差的研究;排除儿科人群、妊娠期及非脱垂用途的子宫托研究。

临床怎么用

  • 作者认为,基于标准化问卷评分的改善,子宫托是盆腔器官脱垂的有效治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the existing evidence on the efficacy of pessaries in improving quality of life when used for the treatment of pelvic organ prolapse (POP). DATA SOURCES: We searched for the terms "pelvic organ prolapse" and "pessar/y/ies/ium or vaginal support device," and "safety or safe or outcome or complication or efficacy or effective or effectiveness" in PubMed, EMBASE, and CINAHL on March 16, 2020. A search was also performed on ClinicalTrials.gov , with no studies fitting our strict inclusion and exclusion criteria. METHODS OF STUDY SELECTION: Studies that reported pretreatment and posttreatment mean scores and SDs after pessary treatment for standardized questionnaires were included. Studies performed in pediatric populations, pregnancy, and use of pessaries not for prolapse were excluded. Three reviewers independently screened studies. TABULATION, INTEGRATION, AND RESULTS: Data abstraction was performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Data were pooled for meta-analysis when reported by at least three studies. The primary study outcome was change in mean pretreatment and posttreatment questionnaire scores, which included those for the PFDI-20 (Pelvic Floor Distress Inventory- Short Form 20), PFIQ-7 (Pelvic Floor Impact Questionnaire - Short Form 7), and subscale POPIQ (Pelvic Organ Prolapse Impact Questionnaire Long Form). A random-effects model was used to combine estimates and capture between-study heterogeneity using the I 2 -statistic. Eight studies including 627 patients were included for systematic review. The mean (SD) age was 63.0±12.2 years, and the majority of patients had stage III prolapse (48.1%) followed by stage II prolapse (43.2%) when reported. Although variable, the majority of studies conducted 3-month follow-up. A negative change in pretreatment and posttreatment scores was noted, signifying improvement after pessary use: PFDI-20 mean change -46.1 (95% CI -65.4 to -26.8); PFIQ-7 mean change -36.0 (95% CI -46.0 to -26.0); POPIQ-7 (Pelvic Organ Prolapse Impact Questionnaire-7) mean change -16.3 (95% CI -26.8 to -5.7). No significant heterogeneity was found. CONCLUSION: Based on improvements in standardized questionnaire scores, pessaries are effective treatment options for POP. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42020172618.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sansone S, Sze C, Eidelberg A, et al. Role of Pessaries in the Treatment of Pelvic Organ Prolapse: A Systematic Review and Meta-analysis. Obstet Gynecol. 2022. PMID: 36075076. doi:10.1097/AOG.0000000000004931

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。